The COMPASSION Study
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorDana-Farber Cancer Institute
About this trial
The aim of this research study is to better understand the in-home hospice experience for participants, caregivers, hospice nurses, and oncology providers by conducting telehealth check-ins between participants and caregivers and oncology care teams.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient of any gender with unresectable locally advanced or metastatic breast cancer
Eligible for in-home hospice services and referred by DFCI clinical team to in-home hospice </= 1 week before enrollment
Ability to conduct video or phone check-ins, even if assistance required.
Able to provide verbal consent with a willingness to take a survey at 4-6 weeks, if medically able
Disqualifiers
Unable to provide verbal consent
Hospice care planned outside of a home setting (note: if participants start out in a home hospice setting but later transition their hospice care to an inpatient setting, enrollment is allowed as long as they started in a home setting)
Hospice setting outside of Massachusetts
Individuals who are under the age of 18, as this is not a project focused on pediatric patients.
Trial design
Design model
Sequential
Treatments tested in this trial
Telehealth Hospice Visits
Other interventionTelehealth check-in appointments with oncology care team, MD, PA, NP, or hospice nurse, via HIPAA compliant telehealth platform, Zoom, or by phone call.
Treatment groups
200 Participants
are divided into 2 treatment groupsGroup A: Usual Care CohortNo intervention 0 interventions
Group B: Compassion CohortExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Proportion of Participant Intervention Completion
Feasibility of the telehealth intervention is defined as greater than or equal to 80% of enrolled participants (18 out of 25) completing greater than or equal to 66% of the planned telehealth check-ins while the participant remains alive.
Time frame
Up to 4 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov